TrialJournal of hematology & oncology2018

Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).

Xu Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.